Keywords: idec, licenses, rights, ph, ii, anticancer, agent
IDEC Licenses Rights To P&U's Ph II Anticancer Agent
Article | 17 February 1997
- IDEC has licensed rights to Pharmacia & Upjohn's topoisomeraseinhibitor 9-aminocamptothecin, a semisynthetic analogue of the plant-derived anticancer drug camptothecin. 9-AC is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
